Advertisement AUTOGENOUS VACCINES OFFER POULTRY PRODUCERS CUSTOMIZED OPTIONS :KLOHFRPPHUFLDOYDFFLQHVDGGUHVVPRVWGLVHDVHV SRXOWU\SURGXFHUVVRPHWLPHVIDFHXQLTXHKHDOWK FKDOOHQJHV7KDW¶VZKHUHDXWRJHQRXVYDFFLQHVRIIHU DFXVWRPL]HGVROXWLRQ COMMERCIAL VS. AUTOGENOUS VACCINES Autogenous vaccines can be an option for producers battling VSHFL¿FVWUDLQVRIGLVHDVHVLQWKHLUÀRFNWKDWFDQ¶WEHDGGUHVVHG ZLWKFRPPHUFLDOO\DYDLODEOHYDFFLQHV³&RPPHUFLDOYDFFLQHV KDYHDEURDGDSSOLFDWLRQDFURVVDOORIWKHLQGXVWU\YHUVXV DXWRJHQRXVYDFFLQHVZKLFKDUHOLPLWHGWRDVSHFL¿FFXVWRPHU RUIDUP´VD\V%RE(YDQV'903K'7HFKQLFDO$GYLVRUIRU (ODQFR$QLPDO+HDOWK ³6SHFL¿FVWUDLQVRIRUJDQLVPVPD\KDYHDQWLJHQLFYDULDWLRQVQRW \HWUHFRJQL]HGE\FRPPHUFLDOO\SUHSDUHGSURGXFWVOHDYLQJELUGV DWULVN´VD\V(YDQV³,QDGGLWLRQQHZO\GLVFRYHUHGYLUDOYDULDQWV PD\QRWKDYH\HWEHHQLQFRUSRUDWHGLQDFRPPHUFLDOYDFFLQH VRJRLQJWKHDXWRJHQRXVURXWHPD\RIIHUDTXLFNHUFXVWRPL]HG UHVSRQVH´KHVD\V ³$XWRJHQRXVYDFFLQHVZHUH¿UVWGHYHORSHGWRJHWXVWKURXJKD SUREOHPEHIRUHWKHUHZDVDFRPPHUFLDOOLFHQVHIRUWKHP´VD\V (YDQV³,WKDVPRUSKHGERWKLQWKHLQGXVWU\DQGLQJRYHUQPHQWDO UHJXODWLRQVWREHFRPHDOLWWOHPRUHÀH[LEOHVRWKDWZHFDQ SURGXFHDVSHFLDOL]HGYDFFLQHIRURXUFXVWRPHUV´ $XWRJHQRXVYDFFLQHVDUHLQDFWLYDWHGYDFFLQHVPDGHIURPEDFWHULDO RUYLUDOLVRODWHVREWDLQHGIURPDVSHFL¿FÀRFNRIOD\HUVEURLOHU EUHHGHUVRUWXUNH\V7KHYDFFLQHLVWKHQXVHGLQRWKHUÀRFNVRQ WKHVDPHSUHPLVHVWRVWLPXODWHLPPXQLW\WRWKDWLVRODWH Autogenous vaccine development &ROOHFWVDPSOHVIURPELUGV ZLWKFOLQLFDOVLJQV ,VRODWHWKHPLFURRUJDQLVP DQGFUHDWHWKHSULPDU\VHHG ([SDQGWKHVHHGWR appropriate titer 0DQXIDFWXUHWKHDQWLJHQYLD bacterial IHUPHQWDWLRQRU tissue culture ,QDFWLYDWHWKHDQWLJHQ 7HVWLQJ (PXOVLI\DQWLJHQLQDYDFFLQH adjuvant 7HVWLQJ 9DFFLQHVKLSSHGWRWKH FXVWRPHU LONG-TERM SOLUTIONS (ODQFRUHFHQWO\RSHQHGDQHZVWDWHRIWKHDUWDXWRJHQRXV YDFFLQHPDQXIDFWXULQJIDFLOLW\'HGLFDWHGVROHO\WR PDQXIDFWXULQJFXVWRPL]HGLQDFWLYDWHGYDFFLQHVIRUWKHSRXOWU\ LQGXVWU\WKHIDFLOLW\UHÀHFWV(ODQFR¶VRQJRLQJFRPPLWPHQWWR PHHWLQJFXVWRPHUV¶VSHFL¿FQHHGV ³7KHSRXOWU\LQGXVWU\QHHGVVROXWLRQVWKDWJREH\RQGRQH VL]H¿WVDOO´VD\V(YDQV³7KHQHZIDFLOLW\LQ:LQVORZ UHÀHFWVRXUFRPPLWPHQWWRSURYLGHRXUFXVWRPHUVZLWK WKHVROXWLRQVWKH\QHHGWREHSURGXFWLYHVXVWDLQDEOHDQG SUR¿WDEOHIRU\HDUVWRFRPH´ ISOLATING THE CAUSE 7KHSURFHVVRIGHYHORSLQJDQDXWRJHQRXVYDFFLQHEHJLQV ZKHQWKHUHDUHLQGLFDWLRQVRIGLVHDVHRQDSRXOWU\IDUPDQG VDPSOHVDUHFROOHFWHGIURPELUGVSUHVHQWLQJFOLQLFDOVLJQV7KH PLFURRUJDQLVPFDXVLQJWKHGLVHDVHLVWKHQLVRODWHGDQGSXUL¿HG 2QFHWKHSULPDU\VHHGLVSXUL¿HGDQGLGHQWL¿HGWKHZRUNEHJLQV DW(ODQFR¶VQHZDXWRJHQRXVYDFFLQHIDFLOLW\LQ:LQVORZ0DLQH 7KHIDFLOLW\LVHTXLSSHGWRGHYHORSWZRFDWHJRULHVRIDXWRJHQRXV vaccines: 9LUDOLVRODWHVVXFKDVUHRYLUXV %DFWHULDOLVRODWHVVXFKDV6DOPRQHOOD DEVELOPING THE VACCINE 2QFHLQWKHODEWKHVHHGLVH[SDQGHGWRUHDFKWKHQHHGHGWLWHUV WRSURGXFHWKHVSHFL¿FYDFFLQH'HSHQGLQJRQWKHFDWHJRU\ RIWKHYDFFLQHYLUDORUEDFWHULDOWKHDQWLJHQLVGHYHORSHG DQGWHVWHGDWHDFKVWDJHRIWKHPDQXIDFWXULQJSURFHVV7KH HPXOVL¿FDWLRQSURFHVVRIWKHYDFFLQHSURGXFWLRQLVFULWLFDODQG PD\KHOSUHGXFHLUULWDWLRQWRWKHELUG Elanco has a facility dedicated to manufacturing autogenous vaccines. 7ROHDUQPRUHDERXWDXWRJHQRXVYDFFLQHVIURP (ODQFRFRQWDFW\RXU(ODQFRVDOHVUHSUHVHQWDWLYH RUWHFKQLFDOFRQVXOWDQW 7KHODEHOFRQWDLQVFRPSOHWHXVHLQIRUPDWLRQLQFOXGLQJFDXWLRQVDQG ZDUQLQJV$OZD\VUHDGXQGHUVWDQGDQGIROORZWKHODEHODQGXVHGLUHFWLRQV Elanco, and the diagonal bar logo are trademarks of Eli Lilly and Compay or its affiliates. © 2017 Eli Lilly and Company or its affiliates. vacc 5949-2 USPBUAVP00064